/
BVS
$13.89-$0.02 (-0.18%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.2B
84M shares
52-week range
$6.26 – $15.89
79% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Change$-0.34
Bioventus Inc. Class A Common Stock
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
www.bioventus.com- Employees
- 950
- IPO / List date
- Feb 11, 2021
- HQ
- DURHAM, NC
Held by traders on TradeandTell
No one on the platform currently holds BVS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 489,460 | $4.5M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BVS yet.
